Antibacterial and antifungal organic compounds are becoming increasingly important for biomedical applications. This study deals with the synthesis, characterization of structures, in silico PASS prediction, and the discovery of antibacterial and antifungal properties based on new sulfanyl-1,4-naphthoquinone derivatives containing an arylamine with a trifluoromethyl group at different positions, which can be further applied in drug discovery and development. The in vitro antimicrobial potential of the newly synthesized compounds was evaluated in a panel of seven bacterial strains (three Gram-positive and four Gram-negative bacteria) and one yeast, with an additional study on antibiofilm activities. The compounds (5b and 5e) were identified as having strong antibacterial efficiency against the human-originated pathogen S. epidermidis, with minimal inhibitory concentration values (4.88 and 2.44 μg mL−1, respectively). The toxicity of both compounds (5b and 5e) was studied in detail to compare these compounds with Cefuroxime (a clinically proven drug). The antibacterial activity of the compound 5f was equal to that of Cefuroxime. Moreover, three compounds (5b, 5e, and 5f) exhibited excellent antibacterial activity, and 5b and 5e were two and four times more active than the reference antimicrobial compound (Cefuroxime), respectively. For this reason, these three compounds (5b, 5e, and 5f) are being considered as promising antibacterial agents. In addition, docking studies were used to better rationalize the action and prediction of the binding modes of these compounds.
A series of 2‐arylamino‐3‐chloro‐1,4‐naphthoquinone derivatives ( 3a – h ) by the reaction of 2,3‐dichloro‐1,4‐naphthoquinone with aryl amines ( 2a – h ) and benzo[ b ]phenazine‐6,11‐dione derivatives ( 4a – c ) by the treatment of 2‐arylamino‐3‐chloro‐1,4‐naphthoquinone derivatives ( 3a – h ) with sodium azide were synthesized and tested for their in vitro antibacterial and antifungal activities. The results suggest that compounds 3d and 3g had potent antifungal activity against Candida albicans (MIC = 78.12 μ g/mL). All synthesized compounds ( 3a – h , 4a – c ) possessed activity against E. faecalis with MIC values of between 312.5 and 1250 μ g/mL. Benzo[ b ]phenazine‐6,11‐dione derivatives ( 4a – c ) were mostly active against Gram‐positive bacteria. The structures of the new members of the series were established on the basis of their spectral properties (IR, 1 H NMR, 13 C NMR, and mass spectrometry).